Literature DB >> 6623065

Potentiation of glucocorticoid activity by 5 beta-dihydrocortisol: its role in glaucoma.

B I Weinstein, G G Gordon, A L Southren.   

Abstract

5 beta-Dihydrocortisol potentiated the threshold level (the smallest dose producing a measurable effect) of topically applied cortisol (0.02 percent) and dexamethasone (0.003 percent) in causing nuclear translocation of the cytosolic glucocorticoid receptor in rabbit iris-ciliary body tissue. 5 beta-Dihydrocortisol accumulates in cells cultured from trabecular meshwork specimens from patients with primary open-angle glaucoma, but not in similar cells derived from nonglaucomatous patients. In view of the sensitivity of patients with primary open-angle glaucoma to the effects of glucocorticoids in raising intraocular pressure, this potentiation may be responsible for the steroid sensitivity and for the ocular hypertension seen in this disorder.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6623065     DOI: 10.1126/science.6623065

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  4 in total

Review 1.  Corticosteroids and glaucoma risk.

Authors:  R C Tripathi; S K Parapuram; B J Tripathi; Y Zhong; K V Chalam
Journal:  Drugs Aging       Date:  1999-12       Impact factor: 3.923

Review 2.  5β-Reduced steroids and human Δ(4)-3-ketosteroid 5β-reductase (AKR1D1).

Authors:  Mo Chen; Trevor M Penning
Journal:  Steroids       Date:  2014-02-08       Impact factor: 2.668

3.  Identification of key lipid metabolites during metabolic dysregulation in the diabetic retinopathy disease mouse model and efficacy of Keluoxin capsule using an UHPLC-MS-based non-targeted lipidomics approach.

Authors:  Nan Ge; Ling Kong; Ai-Hua Zhang; Ye Sun; Man-Qian Zhao; Bo Zhang; Lei Xu; Xiao Ke; Hui Sun; Xi-Jun Wang
Journal:  RSC Adv       Date:  2021-02-01       Impact factor: 3.361

4.  Characterization of rabbit myocilin: Implications for human myocilin glycosylation and signal peptide usage.

Authors:  Allan R Shepard; Nasreen Jacobson; Ruifang Sui; H Thomas Steely; Andrew J Lotery; Edwin M Stone; Abbot F Clark
Journal:  BMC Genet       Date:  2003-04-02       Impact factor: 2.797

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.